Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)
|
November 11, 2018
Characterization of MicroRNAs Regulating FOXO Expression
Doug Hanniford, Eva Hernando
Carcinogenesis
|
June 14, 2012
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy
Miguel F Segura, Holly S Greenwald, Doug Hanniford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2015
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis
Doug Hanniford, Judy Zhong, Lisa Koetz, et al.
Journal of the National Cancer Institute
|
February 14, 2015
Identification of metastasis-suppressive microRNAs in primary melanoma
Doug Hanniford, Miguel F Segura, Judy Zhong, et al.
Cancer
|
August 27, 2014
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
Nathaniel H Fleming, Judy Zhong, Inês Pires da Silva, et al.
Cancer Research
|
August 17, 2013
BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy
Miguel F Segura, Bárbara Fontanals-Cirera, Avital Gaziel-Sovran, et al.
Journal of the National Cancer Institute
|
June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
Michael Lattanzi, Yesung Lee, Danny Simpson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 12, 2010
3-Indolyl sultams as selective CRTh2 antagonists
L Nathan Tumey, Michael J Robarge, Elizabeth Gleason, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists
Michael J Robarge, David C Bom, L Nathan Tumey, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Methods in Molecular Biology (Clifton, N.J.)
|
November 11, 2018
Characterization of MicroRNAs Regulating FOXO Expression
Doug Hanniford, Eva Hernando
Carcinogenesis
|
June 14, 2012
MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy
Miguel F Segura, Holly S Greenwald, Doug Hanniford, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 20, 2015
A miRNA-Based Signature Detected in Primary Melanoma Tissue Predicts Development of Brain Metastasis
Doug Hanniford, Judy Zhong, Lisa Koetz, et al.
Journal of the National Cancer Institute
|
February 14, 2015
Identification of metastasis-suppressive microRNAs in primary melanoma
Doug Hanniford, Miguel F Segura, Judy Zhong, et al.
Cancer
|
August 27, 2014
Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients
Nathaniel H Fleming, Judy Zhong, Inês Pires da Silva, et al.
Cancer Research
|
August 17, 2013
BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy
Miguel F Segura, Bárbara Fontanals-Cirera, Avital Gaziel-Sovran, et al.
Journal of the National Cancer Institute
|
June 19, 2018
Primary Melanoma Histologic Subtype: Impact on Survival and Response to Therapy
Michael Lattanzi, Yesung Lee, Danny Simpson, et al.
Bioorganic & Medicinal Chemistry Letters
|
May 12, 2010
3-Indolyl sultams as selective CRTh2 antagonists
L Nathan Tumey, Michael J Robarge, Elizabeth Gleason, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 5, 2005
Isosteric ramatroban analogs: selective and potent CRTH-2 antagonists
Michael J Robarge, David C Bom, L Nathan Tumey, et al.
Page
of 1